Neuroglee Therapeutics
Neuroglee secures $10m funding to advance home-based Alzheimer's treatment
Neuroglee secures $10m funding to advance home-based Alzheimer's treatment
Openspace Ventures led the Series A round.
Read Here
Advertise
Sign Up
Commentary
Public health at scale: Lessons from implementing AI across government health programmes
Clearing the air: Why Singapore's haze problem is an eldercare crisis in plain sight